Clementia Pharmaceuticals
Latest round
- Series A
Last raised
- Jan 2015
Total raised
- $33M
Investors
- 2
About Clementia Pharmaceuticals
Founded in 2011 and based in Montreal, Quebec, Clementia Pharmaceuticals Inc. is a biopharmaceutical company that develops treatments for patients suffering from ultra-rare bone disorders and other diseases.) selective agonist, for the treatment of individuals with fibrodysplasia ossificans progressiva (FOP), multiple osteochondromas (MO) and dry eye disease.
Who invested in Clementia Pharmaceuticals
2 investors across 2 rounds
See all investors in Clementia Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Clementia Pharmaceuticals
Who invested in Clementia Pharmaceuticals?
Clementia Pharmaceuticals has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Clementia Pharmaceuticals raised?
Clementia Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Clementia Pharmaceuticals last raise money?
Clementia Pharmaceuticals's most recent round on record is a Series A, in Jan 2015.
What does Clementia Pharmaceuticals do?
Founded in 2011 and based in Montreal, Quebec, Clementia Pharmaceuticals Inc.
Where is Clementia Pharmaceuticals headquartered?
Clementia Pharmaceuticals is headquartered in Montreal, Canada.
Which VCs invest in companies like Clementia Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Clementia Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Clementia Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.